A new protein structure may guide the development of Alzheimer's therapeutics.

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.

The dawn of the Animal Kingdom began with a collagen scaffold that enabled the organization of cells into tissues.

Medicaid expansion under the Affordable Care Act provides patients with a greater choice of hospital facilities, Vanderbilt researchers have found.

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).

Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension.